SOLI - Solithromycin Pediatric Development Program (Phase IB)- MOD 2
Clinical Trial Grant
Administered By
Duke Clinical Research Institute
Awarded By
Cempra Pharmaceuticals, Inc.
Start Date
December 1, 2014
End Date
November 30, 2016
Administered By
Duke Clinical Research Institute
Awarded By
Cempra Pharmaceuticals, Inc.
Start Date
December 1, 2014
End Date
November 30, 2016